Viewing Study NCT03188458


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-10 @ 10:40 AM
Study NCT ID: NCT03188458
Status: TERMINATED
Last Update Posted: 2019-02-12
First Post: 2017-05-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunogenicity of a Single Dose of GSK Biologicals' Boostrix™ in Infants Prior to Primary Pertussis Vaccination, When Administered to Pregnant Women as Per Routine Practice in Bogota, Colombia
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module